Verus Capital Partners’s Alkermes ALKS Stock Holding History

Verus Capital Partners’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25	Closed	-$1K	–	1473
2019 Q4	$1K	Buy	+25	New	+$497	﹤0.01%	1462

Other funds holding ALKS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Verus Capital Partners's ALKS Position: Q1 2020 in Review

Verus Capital Partners sold out of Alkermes (ALKS) in Q1 2020, closing a stake of 25 shares — an estimated $1K sold.

Verus Capital Partners first reported a position in ALKS in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 196 funds tracked by Wall St. Rank hold ALKS as of Q1 2020.

Verus Capital Partners reported no remaining Alkermes position as of Q1 2020 after selling out during the quarter.
Verus Capital Partners sold 25 Alkermes shares in Q1 2020, an estimated $1K.
Verus Capital Partners first reported a position in Alkermes in Q4 2019 and held it in 1 quarter.
Verus Capital Partners's Alkermes position peaked at $1K in Q4 2019.
196 funds tracked by Wall St. Rank held Alkermes as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.